Skip to main content
. 2019 Mar;21(2):286–295. doi: 10.1016/j.jmoldx.2018.10.004

Table 2.

Validation of the TR34-LAMP Assay with Clinical Isolates

Type Clinical sample A. fumigatus detection
TR34 mutation detection
LAMP
A. fumigatus
TTP, means ± SD, minutes TR34-LAMP TTP, means ± SD, minutes Estimated concentration
TR34 CL-Asp164 + 23.19 ± 0.25 + 16.45 ± 0.31 7.38 × 103
CL-Asp168 + 23.29 ± 0.50 + 15.85 ± 0.17 1.38 × 104
CL-Asp251 + 24.6 ± 1.14 + 16.03 ± 0.13 1.14 × 104
E076 + 22.23 ± 0.28 + 15.92 ± 0.20 1.28 × 104
TR46 E224 + 22.82 ± 0.27
E357 + 21.32 ± 0.29
E276 + 22.55 ± 0.23
WT E409 + 25.82 ± 0.42
ARAF016 + 22.72 ± 0.21
AF293 + 24.98 ± 0.81
CL-ASP237 + 22.39 ± 0.14

SDs were calculated from replicates.

+, positive reaction; −, negative reaction; A. fumigatus, Aspergillus fumigatus; LAMP, loop-mediated isothermal amplification; TTP, time to positivity (detection within 30-minute timeframe); WT, wild type.

LAMP A. fumigatus, result of LAMP assay by using published LAMP primers43 for A. fumigatus detection.

TR34-LAMP, result of TR34-LAMP assay by using clinical samples.

Estimation of initial concentration (Copy number/Reaction) by linear regression formula [y = −0.96ln(x) + 24.96].